Global Apomorphine Hydrochloride Market Size, Share, Trends and Forecast 2022-2030

Description

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
Industry Insights

Due to the COVID-19 pandemic, the global Apomorphine Hydrochloride market size is estimated to be worth US$ 277.7 million in 2021 and is forecast to a readjusted size of US$ 364.1 million by 2028 with a CAGR of 3.9% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Apomorphine Hydrochloride market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Apomorphine Hydrochloride landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.

Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.

Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.

Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

This report focuses on Apomorphine Hydrochloride volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Apomorphine Hydrochloride market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe and China, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Apomorphine Hydrochloride market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Injection

Tablets

Thinfilm

Nasal Powder (Pipeline)

Segment by Application

Parkinson Disease

Erectile Dysfunction

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Supernus Pharmaceuticals

Britannia Pharmaceuticals STADA

Ever Pharma

Evolan Pharma AB (PharmSwed)

Tianjin Tianwei Pharmaceutical

Sunovion

TABLE OF CONTENT

1 Apomorphine Hydrochloride Market Overview
1.1 Product Overview and Scope of Apomorphine Hydrochloride

1.2 Apomorphine Hydrochloride Segment by Type

1.2.1 Global Apomorphine Hydrochloride Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Injection

1.2.3 Tablets

1.2.4 Thinfilm

1.2.5 Nasal Powder (Pipeline)

1.3 Apomorphine Hydrochloride Segment by Application

1.3.1 Global Apomorphine Hydrochloride Sales Comparison by Application: (2022-2028)

1.3.2 Parkinson Disease

1.3.3 Erectile Dysfunction

1.4 Global Apomorphine Hydrochloride Market Size Estimates and Forecasts

1.4.1 Global Apomorphine Hydrochloride Revenue 2017-2028

1.4.2 Global Apomorphine Hydrochloride Sales 2017-2028

1.4.3 Apomorphine Hydrochloride Market Size by Region: 2017 Versus 2021 Versus 2028

2 Apomorphine Hydrochloride Market Competition by Manufacturers

2.1 Global Apomorphine Hydrochloride Sales Market Share by Manufacturers (2017-2022)

2.2 Global Apomorphine Hydrochloride Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Apomorphine Hydrochloride Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Apomorphine Hydrochloride Manufacturing Sites, Area Served, Product Type

2.5 Apomorphine Hydrochloride Market Competitive Situation and Trends

2.5.1 Apomorphine Hydrochloride Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Apomorphine Hydrochloride Players Market Share by Revenue

2.5.3 Global Apomorphine Hydrochloride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Apomorphine Hydrochloride Retrospective Market Scenario by Region

3.1 Global Apomorphine Hydrochloride Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Apomorphine Hydrochloride Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Apomorphine Hydrochloride Market Facts & Figures by Country

3.3.1 North America Apomorphine Hydrochloride Sales by Country

3.3.2 North America Apomorphine Hydrochloride Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Apomorphine Hydrochloride Market Facts & Figures by Country

3.4.1 Europe Apomorphine Hydrochloride Sales by Country

3.4.2 Europe Apomorphine Hydrochloride Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Apomorphine Hydrochloride Market Facts & Figures by Region

3.5.1 Asia Pacific Apomorphine Hydrochloride Sales by Region

3.5.2 Asia Pacific Apomorphine Hydrochloride Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Apomorphine Hydrochloride Market Facts & Figures by Country

3.6.1 Latin America Apomorphine Hydrochloride Sales by Country

3.6.2 Latin America Apomorphine Hydrochloride Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Apomorphine Hydrochloride Market Facts & Figures by Country

3.7.1 Middle East and Africa Apomorphine Hydrochloride Sales by Country

3.7.2 Middle East and Africa Apomorphine Hydrochloride Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Apomorphine Hydrochloride Historic Market Analysis by Type

4.1 Global Apomorphine Hydrochloride Sales Market Share by Type (2017-2022)

4.2 Global Apomorphine Hydrochloride Revenue Market Share by Type (2017-2022)

4.3 Global Apomorphine Hydrochloride Price by Type (2017-2022)

5 Global Apomorphine Hydrochloride Historic Market Analysis by Application

5.1 Global Apomorphine Hydrochloride Sales Market Share by Application (2017-2022)

5.2 Global Apomorphine Hydrochloride Revenue Market Share by Application (2017-2022)

5.3 Global Apomorphine Hydrochloride Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Supernus Pharmaceuticals

6.1.1 Supernus Pharmaceuticals Corporation Information

6.1.2 Supernus Pharmaceuticals Description and Business Overview

6.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolio

6.1.5 Supernus Pharmaceuticals Recent Developments/Updates

6.2 Britannia Pharmaceuticals STADA

6.2.1 Britannia Pharmaceuticals STADA Corporation Information

6.2.2 Britannia Pharmaceuticals STADA Description and Business Overview

6.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolio

6.2.5 Britannia Pharmaceuticals STADA Recent Developments/Updates

6.3 Ever Pharma

6.3.1 Ever Pharma Corporation Information

6.3.2 Ever Pharma Description and Business Overview

6.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Ever Pharma Apomorphine Hydrochloride Product Portfolio

6.3.5 Ever Pharma Recent Developments/Updates

6.4 Evolan Pharma AB (PharmSwed)

6.4.1 Evolan Pharma AB (PharmSwed) Corporation Information

6.4.2 Evolan Pharma AB (PharmSwed) Description and Business Overview

6.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolio

6.4.5 Evolan Pharma AB (PharmSwed) Recent Developments/Updates

6.5 Tianjin Tianwei Pharmaceutical

6.5.1 Tianjin Tianwei Pharmaceutical Corporation Information

6.5.2 Tianjin Tianwei Pharmaceutical Description and Business Overview

6.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolio

6.5.5 Tianjin Tianwei Pharmaceutical Recent Developments/Updates

6.6 Sunovion

6.6.1 Sunovion Corporation Information

6.6.2 Sunovion Description and Business Overview

6.6.3 Sunovion Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Sunovion Apomorphine Hydrochloride Product Portfolio

6.6.5 Sunovion Recent Developments/Updates

7 Apomorphine Hydrochloride Manufacturing Cost Analysis

7.1 Apomorphine Hydrochloride Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Apomorphine Hydrochloride

7.4 Apomorphine Hydrochloride Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Apomorphine Hydrochloride Distributors List

8.3 Apomorphine Hydrochloride Customers

9 Apomorphine Hydrochloride Market Dynamics

9.1 Apomorphine Hydrochloride Industry Trends

9.2 Apomorphine Hydrochloride Market Drivers

9.3 Apomorphine Hydrochloride Market Challenges

9.4 Apomorphine Hydrochloride Market Restraints

10 Global Market Forecast

10.1 Apomorphine Hydrochloride Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Apomorphine Hydrochloride by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Apomorphine Hydrochloride by Type (2023-2028)

10.2 Apomorphine Hydrochloride Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Apomorphine Hydrochloride by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Apomorphine Hydrochloride by Application (2023-2028)

10.3 Apomorphine Hydrochloride Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Apomorphine Hydrochloride by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Apomorphine Hydrochloride by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample